advertisement
eLife 27
Showing records 1 to 25 | Display all abstracts in eLife128012 Glaucoma-associated Optineurin mutations increase transcellular degradation of mitochondria in a vertebrate optic nerve
Jeong Y
eLife 2025; 14:
127744 TRPV4 activation by TGFβ2 enhances cellular contractility and drives ocular hypertension
Rudzitis CN
eLife 2025; 14:
127703 Magnetically steered cell therapy for reduction of intraocular pressure as a treatment strategy for open-angle glaucoma
Bahranifard MR
eLife 2025; 13:
128012 Glaucoma-associated Optineurin mutations increase transcellular degradation of mitochondria in a vertebrate optic nerve
Davis CO
eLife 2025; 14:
127744 TRPV4 activation by TGFβ2 enhances cellular contractility and drives ocular hypertension
Lakk M
eLife 2025; 14:
127703 Magnetically steered cell therapy for reduction of intraocular pressure as a treatment strategy for open-angle glaucoma
Chan J
eLife 2025; 13:
128012 Glaucoma-associated Optineurin mutations increase transcellular degradation of mitochondria in a vertebrate optic nerve
Muscarella A
eLife 2025; 14:
127744 TRPV4 activation by TGFβ2 enhances cellular contractility and drives ocular hypertension
Singh A
eLife 2025; 14:
127703 Magnetically steered cell therapy for reduction of intraocular pressure as a treatment strategy for open-angle glaucoma
Read AT
eLife 2025; 13:
128012 Glaucoma-associated Optineurin mutations increase transcellular degradation of mitochondria in a vertebrate optic nerve
Navarro HH
eLife 2025; 14:
127744 TRPV4 activation by TGFβ2 enhances cellular contractility and drives ocular hypertension
Redmon SN
eLife 2025; 14:
127703 Magnetically steered cell therapy for reduction of intraocular pressure as a treatment strategy for open-angle glaucoma
Li G; Cheng L
eLife 2025; 13:
128012 Glaucoma-associated Optineurin mutations increase transcellular degradation of mitochondria in a vertebrate optic nerve
Deshpande V
eLife 2025; 14:
127744 TRPV4 activation by TGFβ2 enhances cellular contractility and drives ocular hypertension
Kirdajová D
eLife 2025; 14:
128012 Glaucoma-associated Optineurin mutations increase transcellular degradation of mitochondria in a vertebrate optic nerve
Moore LG
eLife 2025; 14:
127744 TRPV4 activation by TGFβ2 enhances cellular contractility and drives ocular hypertension
Tseng YT
eLife 2025; 14:
127703 Magnetically steered cell therapy for reduction of intraocular pressure as a treatment strategy for open-angle glaucoma
Safa BN
eLife 2025; 13:
128012 Glaucoma-associated Optineurin mutations increase transcellular degradation of mitochondria in a vertebrate optic nerve
Kim KY
eLife 2025; 14:
127744 TRPV4 activation by TGFβ2 enhances cellular contractility and drives ocular hypertension
De Ieso ML
eLife 2025; 14:
127703 Magnetically steered cell therapy for reduction of intraocular pressure as a treatment strategy for open-angle glaucoma
Siadat SM
eLife 2025; 13:
127744 TRPV4 activation by TGFβ2 enhances cellular contractility and drives ocular hypertension
Stamer WD
eLife 2025; 14:
127703 Magnetically steered cell therapy for reduction of intraocular pressure as a treatment strategy for open-angle glaucoma
Jhunjhunwala A
eLife 2025; 13:
128012 Glaucoma-associated Optineurin mutations increase transcellular degradation of mitochondria in a vertebrate optic nerve
Ellisman MH; Marsh-Armstrong N
eLife 2025; 14:
127744 TRPV4 activation by TGFβ2 enhances cellular contractility and drives ocular hypertension
Herberg S
eLife 2025; 14:
127703 Magnetically steered cell therapy for reduction of intraocular pressure as a treatment strategy for open-angle glaucoma
Grossniklaus HE
eLife 2025; 13:
